The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

radiorx.com

Founded Year

2002

Stage

Series A - IV | Dead

Total Raised

$20.45M

Last Raised

$3.96M

About RadioRx

RadioRx discovers and develops compounds sourced and adapted from the aerospace industry for treating cancer and other indications. RadioRx’s lead compound is called RRx-001, a structurally unique pharmacophore with novel mechanisms of action (MOA) that are not cross-resistant with approved therapies and that selectively target the microenvironment of the tumor vasculature through a self-amplifying cycle of nitric oxide, free radical, chemokine and cytokine generation under hypoxia. Since RRx-001 increases oxidative stress in tumors, it literally represents a radical approach to cancer treatment.

RadioRx Headquarter Location

800 W El Camino Real Suite 180

Mountain View, California, 94040,

United States

650-396-4450

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RadioRx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RadioRx is included in 1 Expert Collection, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

RadioRx Patents

RadioRx has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/26/2013

9/15/2015

Alkene derivatives, Alkynes, Organic reactions, Ketones, Coupling reactions

Grant

Application Date

7/26/2013

Grant Date

9/15/2015

Title

Related Topics

Alkene derivatives, Alkynes, Organic reactions, Ketones, Coupling reactions

Status

Grant

  • When was RadioRx founded?

    RadioRx was founded in 2002.

  • Where is RadioRx's headquarters?

    RadioRx's headquarters is located at 800 W El Camino Real, Mountain View.

  • What is RadioRx's latest funding round?

    RadioRx's latest funding round is Series A - IV.

  • How much did RadioRx raise?

    RadioRx raised a total of $20.45M.

  • Who are the investors of RadioRx?

    Investors of RadioRx include InterWest Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.